Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03039647 · ClinicalTrials.gov registry record
Insulin Resistance and Accelerated Cognitive Aging
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 126
- Enrollment target
NCT03039647: Completed study, sponsored by Stanford University.
NCT03039647 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 126 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03039647 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 126 participants
- Enrollment target
Study Summary
Premature and accelerated brain aging trajectories have been observed among people with metabolic dysfunction, but mechanisms of these altered trajectories are not understood. Insulin resistance (IR) is known to change with age and affect cognition in older and elderly adults as well as in patients with mood disorders. The main purpose of the study is to describe the developmental trajectory of cognitive and neural biomarkers across the spectrum of metabolic dysfunction in overweight/obese adults younger than 50 years of age. The innovative study design will allow the investigators to examine cognitive outcome development over a 25-year span without an investment into the longitudinal observation of changes in cognition and neural function.
Primary Outcome
This will be assessed by MRI and cognitive assessments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 126 participants |
| Start Date | 2017-01-01 |
| Est. Completion | 2022-05-01 |
What the finished NCT03039647 record still lists
NCT03039647 is an observational study that tracks outcomes without assigning an intervention. The registered 126 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03039647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03039647 about?
NCT03039647 is a clinical study titled "Insulin Resistance and Accelerated Cognitive Aging". Premature and accelerated brain aging trajectories have been observed among people with metabolic dysfunction, but mechanisms of these altered trajectories are not understood. Insulin resistance (IR) is known to change with age and affect cognition in older and elderly adults as well as in patients ...
What is the current status of trial NCT03039647?
This trial is currently completed. The enrollment target is 126 participants. The study started on 2017-01-01. Estimated completion is 2022-05-01.
Who is sponsoring clinical trial NCT03039647?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01873131 · 126 participants · NA
A Clinical Trial of Pulsed-dye Laser Versus Timolol Topical Solution Versus Observation on the Growth of Hemangioma in Newborn
- NCT02621645 · 126 participants · Phase 4
TRAP Intervention STudy: Early Versus Late Intervention for Twin Reversed Arterial Perfusion Sequence
- NCT03838107 · 126 participants
Markers of Trajectory in Pediatric CRPS
- NCT03906422 · 126 participants · NA
Comparison of Patient-reported Pain After Initial Archwire Placement
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI